CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 186 enrolled
Drug / intervention
green tea polyphenols (STA-2)drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01239511
NCT01239511Phase 2Completed
CompareCT.gov

A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Dose-Response and Safety of STA-2 in Patients With Chronic Stable Angina

Sinphar Pharmaceutical Co., Ltd·interventional·Posted Nov 11, 2010·Updated Aug 27, 2014

In Brief

A Phase 2 clinical trial evaluating green tea polyphenols (STA-2) for Chronic Stable Angina. Completed, enrolled 186 participants across 5 sites.

Detailed Summary

The objective of this study is to evaluate the dose-response of three different dose levels of STA-2 (900 mg daily, 1800 mg daily and 2700 mg daily for 42 days) versus placebo in patients with chronic stable angina.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Stable Angina
CountriesTaiwan
Collaborators--

Timeline

Phase 2CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedNov 11, 2010
Enrollment StartNov 1, 2010
Primary CompletionApr 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 15.6 years ago

Interventions

green tea polyphenols (STA-2)drug

2 capsules t.i.d., after meal